BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17090288)

  • 1. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
    Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
    Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
    [No Abstract]   [Full Text] [Related]  

  • 2. Crohn's colitis presenting with node-negative colon cancer and liver metastasis after therapy with infliximab: report of two cases.
    Nicholson T; Orangio GR; Brandenburg D; Wolf DC; Pennington EE
    Dis Colon Rectum; 2005 Aug; 48(8):1651-5. PubMed ID: 15933793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early obstructive colon after treatment of active refractory Crohn's disease with infliximab].
    Belaiche J; Louis E
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1045-7. PubMed ID: 14732856
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulomatous pneumonitis, sclerosing cholangitis, and pancreatitis in a child with Crohn disease: response to infliximab.
    Silbermintz A; Krishnan S; Banquet A; Markowitz J
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):324-6. PubMed ID: 16540804
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated primary varicella after initiation of infliximab for Crohn's disease.
    Leung VS; Nguyen MT; Bush TM
    Am J Gastroenterol; 2004 Dec; 99(12):2503-4. PubMed ID: 15571606
    [No Abstract]   [Full Text] [Related]  

  • 6. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A; Papadatou B; Knafelz D; Gambarara M; Ferretti F; Castro M
    Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of pustular lesions during infliximab therapy for Crohn's disease.
    Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
    Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient.
    Sofos S; Savoye G; Ramirez S; Bauer F; Lerebours E
    Am J Gastroenterol; 2007 Jan; 102(1):217-9. PubMed ID: 17278277
    [No Abstract]   [Full Text] [Related]  

  • 9. Anorectal carcinoma after infliximab therapy in Crohn's disease: report of a case.
    Melichar B; Bures J; Dedic K
    Dis Colon Rectum; 2006 Aug; 49(8):1228-33. PubMed ID: 16845561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
    Peramiquel L; Puig L; Dalmau J; Ricart E; Roe E; Alomar A
    Clin Exp Dermatol; 2005 Nov; 30(6):713-4. PubMed ID: 16197398
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC; Stokkers P; Riemens SC; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab treatment and pregnancy outcome in active Crohn's disease.
    Srinivasan R
    Am J Gastroenterol; 2001 Jul; 96(7):2274-5. PubMed ID: 11467677
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
    Medkour F; Babai S; Chanteloup E; Buffard V; Delchier JC; Le-Louet H
    Gastroenterol Clin Biol; 2010 Feb; 34(2):140-1. PubMed ID: 20138448
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
    Moss AC; Treister NS; Marsee DK; Cheifetz AS
    Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR
    Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract]   [Full Text] [Related]  

  • 16. [Crohn's disease, primary sclerosing cholangitis and antiphospholipid syndrome: an uncommon association].
    Romdhane H; Karoui S; Serghini M; Boubaker J; Filali A
    Tunis Med; 2009 May; 87(5):349-51. PubMed ID: 19927768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for ulcerative colitis following liver transplantation.
    Lal S; Steinhart AH
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
    Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression of colonic lymphoma following infliximab and azathioprine withdrawal in patients with Crohn's disease.
    Flynn AD; Azar JM; Chiorean MV
    Inflamm Bowel Dis; 2013 Apr; 19(5):E69-70. PubMed ID: 23399737
    [No Abstract]   [Full Text] [Related]  

  • 20. Timing infliximab therapy in pediatric Crohn's disease.
    Kirschner BS; Huo D
    Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.